• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CTLA-4在T细胞亚群中的差异表达。

Differential expression of CTLA-4 among T cell subsets.

作者信息

Jago C B, Yates J, Câmara N Olsen Saraiva, Lechler R I, Lombardi G

机构信息

Department of Immunology, Imperial College London, London, UK.

出版信息

Clin Exp Immunol. 2004 Jun;136(3):463-71. doi: 10.1111/j.1365-2249.2004.02478.x.

DOI:10.1111/j.1365-2249.2004.02478.x
PMID:15147348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1809051/
Abstract

CTLA-4 (CD152), the CD28 homologue, is a costimulatory molecule with negative effects on T cell activation. In addition to its role in the termination of activation, CTLA-4 has been implicated in anergy induction and the function of regulatory cells. As an intracellular molecule, it must first relocate to the cell surface and be ligated, in order to inhibit activation. Although some studies have investigated CTLA-4 expression on CD4(+) T cells, evidence is lacking regarding the kinetics of expression, and expression on T cell subpopulations. We have investigated CTLA-4 kinetics on human purified peripheral CD4(+), naïve, memory, CD4(+)CD25(-), CD4(+)CD25(+) regulatory T cells, and T cell clones. Intracellular stores of CTLA-4 were shown to be very low in naïve T cells, whilst significant amounts were present in memory T cells and T cell clones. Cell surface CTLA-4 expression was then investigated on CD4(+)CD45RA(+) (naïve), CD4(+)CD45RO(+) (memory), CD4(+)CD25(-), and CD4(+)CD25(+) T cells. CD25 and CD45RO are both expressed by regulatory T cells. On naïve and CD4(+)CD25(-) T cells, CTLA-4 expression declined after four hours. In contrast, on memory and CD4(+)CD25(+) T cells, high levels of expression were maintained until at least 48 hours. In addition, significant CTLA-4 expression was observed on T cell clones following anergy induction, indicating the potential involvement of CTLA-4 also in this form of tolerance.

摘要

CTLA-4(CD152)是CD28的同源物,是一种对T细胞活化具有负性作用的共刺激分子。除了在活化终止中发挥作用外,CTLA-4还与无反应性诱导和调节性细胞的功能有关。作为一种细胞内分子,它必须首先重新定位到细胞表面并被连接,以便抑制活化。尽管一些研究已经调查了CD4(+) T细胞上CTLA-4的表达,但关于表达动力学以及T细胞亚群上的表达情况仍缺乏证据。我们研究了人纯化外周血CD4(+)、初始、记忆、CD4(+)CD25(-)、CD4(+)CD25(+)调节性T细胞以及T细胞克隆上CTLA-4的动力学。结果显示,初始T细胞中CTLA-4的细胞内储存量非常低,而记忆T细胞和T细胞克隆中存在大量CTLA-4。随后我们研究了CD4(+)CD45RA(+)(初始)、CD4(+)CD45RO(+)(记忆)、CD4(+)CD25(-)和CD4(+)CD25(+) T细胞上的细胞表面CTLA-4表达。CD25和CD45RO均由调节性T细胞表达。在初始和CD4(+)CD25(-) T细胞上,4小时后CTLA-4表达下降。相比之下,在记忆和CD4(+)CD25(+) T细胞上,高水平表达至少维持到48小时。此外,在无反应性诱导后的T细胞克隆上观察到显著的CTLA-4表达,表明CTLA-4也可能参与这种形式的耐受性。

相似文献

1
Differential expression of CTLA-4 among T cell subsets.CTLA-4在T细胞亚群中的差异表达。
Clin Exp Immunol. 2004 Jun;136(3):463-71. doi: 10.1111/j.1365-2249.2004.02478.x.
2
Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.细胞表面CD28水平定义了四个CD4+ T细胞亚群:类风湿性关节炎中的异常表达。
Clin Immunol. 2001 May;99(2):253-65. doi: 10.1006/clim.2001.5003.
3
Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression.人类CD4+CD25+调节性T细胞的抑制特性依赖于CTLA-4的表达。
Eur J Immunol. 2004 Dec;34(12):3485-96. doi: 10.1002/eji.200324632.
4
Activation requirements for the induction of CD4+CD25+ T cell suppressor function.诱导CD4+CD25+ T细胞抑制功能的激活要求。
Eur J Immunol. 2004 Feb;34(2):366-76. doi: 10.1002/eji.200324455.
5
Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.CD4(+)CD25(high)调节性T细胞频率增加会抑制结核病患者CD4(+)T细胞对卡介苗特异性的γ干扰素诱导。
Tuberculosis (Edinb). 2007 Nov;87(6):526-34. doi: 10.1016/j.tube.2007.07.004. Epub 2007 Sep 11.
6
Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70.通过CD27/CD70实现CD45R0与CD45RA T细胞亚群之间的直接细胞通讯。
J Immunol. 1995 Apr 15;154(8):3627-35.
7
CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene.人类脐带血中的CD25+CD4+ T细胞:具有幼稚表型和叉头框p3(Foxp3)基因特异性表达的免疫调节亚群。
Exp Hematol. 2004 Jul;32(7):622-9. doi: 10.1016/j.exphem.2004.03.012.
8
Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.通过体内和体外自然产生的Foxp3 + CD25 + CD4 +调节性T细胞的抗原特异性扩增诱导抗原特异性免疫耐受。
Int Immunol. 2004 Aug;16(8):1189-201. doi: 10.1093/intimm/dxh122. Epub 2004 Jul 5.
9
Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.细胞免疫在系统性硬化症发病机制中的作用:CD4 + T细胞群体研究进展
Roum Arch Microbiol Immunol. 2009 Jan-Mar;68(1):5-13.
10
CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions.CD27是神经生长因子受体家族的一员,在CD45RA+ CD4 T细胞克隆上优先表达,并参与不同的免疫调节功能。
J Immunol. 1992 Nov 15;149(10):3208-16.

引用本文的文献

1
Incidence of pneumonitis with CTLA-4 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis.非小细胞肺癌中使用CTLA-4抑制剂引发肺炎的发生率:一项系统评价和荟萃分析
Front Med (Lausanne). 2025 Aug 6;12:1614442. doi: 10.3389/fmed.2025.1614442. eCollection 2025.
2
Emerging new immune checkpoint inhibitors in solid tumor immunotherapy.实体瘤免疫治疗中新兴的新型免疫检查点抑制剂
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 11. doi: 10.1007/s00210-025-04131-w.
3
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.免疫检查点与非编码RNA:血液系统恶性肿瘤的开创性免疫治疗方法
Cancer Cell Int. 2024 Dec 19;24(1):410. doi: 10.1186/s12935-024-03596-8.
4
Comprehensive proteomic analysis of the differential expression of 62 proteins following intracortical microelectrode implantation.皮质内微电极植入后 62 种蛋白差异表达的全面蛋白质组学分析。
Sci Rep. 2024 Jul 30;14(1):17596. doi: 10.1038/s41598-024-68017-2.
5
Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis.吞噬细胞与 T 细胞间的串扰及其与动脉粥样硬化的相关性。
Front Immunol. 2024 May 30;15:1403150. doi: 10.3389/fimmu.2024.1403150. eCollection 2024.
6
Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review.诊断与管理免疫检查点抑制剂相关葡萄膜炎:综述
Diagnostics (Basel). 2024 Feb 4;14(3):336. doi: 10.3390/diagnostics14030336.
7
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors.组合阻断癌症免疫疗法:针对新兴免疫检查点受体。
Front Immunol. 2023 Oct 19;14:1264327. doi: 10.3389/fimmu.2023.1264327. eCollection 2023.
8
Immune checkpoint inhibitor-related myocarditis: current understanding and potential diagnostic and therapeutic strategies.免疫检查点抑制剂相关心肌炎:当前认识和潜在的诊断及治疗策略。
Expert Opin Drug Saf. 2023 Jul-Dec;22(10):909-919. doi: 10.1080/14740338.2023.2254218. Epub 2023 Sep 4.
9
Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.肿瘤免疫微环境中癌细胞与免疫细胞的串扰:潜在的治疗靶点。
Mol Cancer. 2023 Feb 21;22(1):38. doi: 10.1186/s12943-023-01748-4.
10
A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?复发或难治性非霍奇金淋巴瘤免疫检查点疗法的系统评价和荟萃分析:是友还是敌?
Transl Oncol. 2023 Apr;30:101636. doi: 10.1016/j.tranon.2023.101636. Epub 2023 Feb 9.

本文引用的文献

1
Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells.人CD4+CD25+调节性T细胞对抗原特异性T细胞的抑制作用。
Eur J Immunol. 2002 Jun;32(6):1621-30. doi: 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q.
2
CD4+ CD25+ suppressor T cells: more questions than answers.CD4+ CD25+ 抑制性T细胞:问题多于答案。
Nat Rev Immunol. 2002 Jun;2(6):389-400. doi: 10.1038/nri821.
3
Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.细胞毒性T淋巴细胞抗原4和CD28在调节T细胞功能时可调节细胞表面脂筏的表达。
J Exp Med. 2001 Dec 3;194(11):1675-81. doi: 10.1084/jem.194.11.1675.
4
Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells.人类外周血T细胞上CTLA-4的表面及细胞内表达调控
Scand J Immunol. 2001 Nov;54(5):453-8. doi: 10.1046/j.1365-3083.2001.00985.x.
5
CTLA-4 blockade of antigen-induced cell death.CTLA-4对抗原诱导的细胞死亡的阻断作用。
Blood. 2001 Feb 15;97(4):1134-7. doi: 10.1182/blood.v97.4.1134.
6
CD28, CTLA-4 and their ligands: who does what and to whom?CD28、细胞毒性T淋巴细胞相关抗原4及其配体:各自作用于谁及发挥何种作用?
Immunology. 2000 Oct;101(2):169-77. doi: 10.1046/j.1365-2567.2000.00121.x.
7
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.由持续表达细胞毒性T淋巴细胞相关抗原4的CD25(+)CD4(+)调节性T细胞维持的免疫自身耐受性。
J Exp Med. 2000 Jul 17;192(2):303-10. doi: 10.1084/jem.192.2.303.
8
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.细胞毒性T淋巴细胞相关抗原4在控制肠道炎症的CD25(+)CD4(+)调节性细胞的功能中发挥着重要作用。
J Exp Med. 2000 Jul 17;192(2):295-302. doi: 10.1084/jem.192.2.295.
9
Structural analysis of CTLA-4 function in vivo.体内CTLA-4功能的结构分析。
J Immunol. 2000 May 15;164(10):5319-27. doi: 10.4049/jimmunol.164.10.5319.
10
Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders.小鼠和人类CTLA4基因座的完整序列测定:外显子边界之外的跨物种DNA序列相似性
Genomics. 1999 Sep 15;60(3):341-55. doi: 10.1006/geno.1999.5930.